S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/RA Capital Management/Q4 2022

RA Capital Management

Periodo: Q4 2022 Β· Depositato: 2023-02-14
Vedi su SEC EDGAR β†—
AUM
$4.93B
Valore totale del portafoglio
Posizioni
70
Titoli dichiarati
Prima Posizione
ASND
17.2% $849.7M
Var. Trimestrali
+8 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2023-02-14) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
ASNDASCENDIS PHARMA A/S$849.7M17.23%$120.72$274.50+127.4%
17.2%
PCVXVAXCYTE INC$280.9M5.70%$47.20$58.39+23.7%
5.7%
AVTEAEROVATE THERAPEUTICS INC$242.1M4.91%β€”β€”
4.9%
DICEDICE THERAPEUTICS INC$213.7M4.33%β€”β€”
4.3%
VRNAVERONA PHARMA PLC$165.1M3.35%β€”β€”
3.4%
RYTMRHYTHM PHARMACEUTICALS INC$160.6M3.26%$28.64$114.17+298.6%
3.3%
DAWNDAY ONE BIOPHARMACEUTICALS I$151.5M3.07%β€”β€”
3.1%
VORXXXXVOR BIOPHARMA INC$151.3M3.07%β€”β€”
3.1%
BIIBBIOGEN INC$147.6M2.99%$272.63$216.12-20.7%
3.0%
CTKBCYTEK BIOSCIENCES INC$136.6M2.77%$10.12$4.59-54.6%
2.8%
LEGNLEGEND BIOTECH CORP$121.6M2.47%$48.70$29.91-38.6%
2.5%
RNAMAVIDITY BIOSCIENCES INC$121.0M2.45%β€”β€”
2.5%
WVEWAVE LIFE SCIENCES LTD$120.4M2.44%$6.20$6.26+1.0%
2.4%
JANXJANUX THERAPEUTICS INC$114.2M2.32%$14.02$15.54+10.8%
2.3%
ETNB89BIO INC$114.0M2.31%β€”β€”
2.3%
PEPGPEPGEN INC$108.7M2.21%$13.33$1.76-86.8%
2.2%
IMGNIMMUNOGEN INC$108.4M2.20%β€”β€”
2.2%
BLUBELLUS HEALTH INC NEW$102.4M2.08%β€”β€”
2.1%
INBXINHIBRX INC$95.0M1.93%β€”$97.58
1.9%
CLDXCELLDEX THERAPEUTICS INC NEW$92.5M1.88%$43.39$38.37-11.6%
1.9%
ITOSITEOS THERAPEUTICS INC$86.3M1.75%β€”β€”
1.8%
TVTXTRAVERE THERAPEUTICS INC$83.8M1.70%$20.66$56.92+175.5%
1.7%
COGTCOGENT COMMUNICATIONS HLDGS$69.3M1.41%$11.07$38.69+249.5%
1.4%
ACRSACLARIS THERAPEUTICS INC$69.3M1.40%$15.07$5.56-63.1%
1.4%
FULCFULCRUM THERAPEUTICS INC$69.2M1.40%$7.90$3.84-51.4%
1.4%
ACRVACRIVON THERAPEUTICS INC$55.4M1.12%$11.57$1.72-85.1%
1.1%
TYRATYRA BIOSCIENCES INC$55.0M1.12%$7.07$30.62+333.1%
1.1%
ABOSACUMEN PHARMACEUTICALS INC$52.8M1.07%$5.26$2.74-47.9%
1.1%
AKROAKERO THERAPEUTICS INC$52.5M1.07%β€”β€”
1.1%
CLYMELIEM THERAPEUTICS INC$48.3M0.98%$3.31$12.90+289.7%
1.0%

AttivitΓ  Trimestre su Trimestre

Q4 2022 vs. Q3 2022

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
INBXINHIBRX INC$95.0M
ACRVACRIVON THERAPEUTICS INC$55.4M-85.1%
NAMSNEWAMSTERDAM PHARMA COMPANY$43.6M
SPRYARS PHARMACEUTICALS INC$25.7M
CELCCELCUITY INC$19.6M
SLDBSOLID BIOSCIENCES INC$18.4M
SCPHSCPHARMACEUTICALS INC$13.3M
IMRAIMARA INC$13.3M

Posizioni Chiuse (8)

TickerEmittenteNozionale
FMTXFORMA THERAPEUTICS HLDGS INC$179.8M
RLMDRELMADA THERAPEUTICS INC$74.0M
ENTAENANTA PHARMACEUTICALS INC$46.5M
TILINSTIL BIO INC$37.1M
VERAVERA THERAPEUTICS INC$33.6M
ACETADICET BIO INC$29.3M
MISTMILESTONE PHARMACEUTICALS IN$20.6M
PMVPPMV PHARMACEUTICALS INC$20.4M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
TNYATENAYA THERAPEUTICS INC$7.5M+278.7%
RNAMAVIDITY BIOSCIENCES INC$85.6M+151.7%
VORXXXXVOR BIOPHARMA INC$107.0M+104.6%
COGTCOGENT COMMUNICATIONS HLDGS$9.5M+49.5%+249.5%
FULCFULCRUM THERAPEUTICS INC$12.6M+35.8%-51.4%
DICEDICE THERAPEUTICS INC$108.0M+31.5%
PCVXVAXCYTE INC$170.9M+27.9%+23.7%
ETNB89BIO INC$68.9M+15.1%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
NSTGQNANOSTRING TECHNOLOGIES$-57.6M-96.9%
ENTXENTERA BIO LTD$-1.9M-85.8%
THRDTHIRD HARMONIC BIO INC$-63.6M-84.6%
ACHLACHILLES THERAPEUTICS PLC$-9.9M-67.9%
GERNGERON CORP$-39.2M-57.1%
DBVTDBV TECHNOLOGIES S A$-3.6M-47.4%
BIIBBIOGEN INC$-102.8M-43.2%-20.7%
IOBTQIO BIOTECH INC$-2.4M-39.3%
← Torna agli Hedge Fund